Since then, mentioning cold fusion is right up there with perpetual motion. Work does continue though, and NASA recently published several papers on lattice confinement fusion which is definitely ...

The first drug based on 'Trap ... cold auto-inflammatory syndrome and Muckle-Wells syndrome. Arcalyst is a first-in-class drug designed using Regeneron's 'Trap' technology. The drug is a fusion ...

These modular cold fusion reactors processing plants can fracture harmful radioactive legacy fission waste products and also aid in cleansing of localized fission type Small Modular Reactors (SMR).

Hylenr Technologies, a Hyderabad, India-based clean energy startup, has signed a Memorandum of Understanding (MoU) with TakeMe2Space to develop and test Low Energy Nuclear Reactor-powered compute ...

The first drug based on 'Trap ... cold auto-inflammatory syndrome and Muckle-Wells syndrome. Arcalyst is a first-in-class drug designed using Regeneron's 'Trap' technology. The drug is a fusion ...